Medtronic: Buy for a 3% Yield and Improving Cash-Flow Momentum
Medtronic offers a mix of reliable income (3.1% yield), above-market top-line momentum and a valuation that still leaves upside if execution on robotics and cardiac growth continues. This trade targets a measured long-term move over 180 trading days with explicit entry, stop and target levels.